Note: As compared to the Hemopurifier(TM), we designed Sigyn Therapy(TM) with the intent to process the bloodstream more efficiently; to have a greater capacity to capture therapeutic targets ...

Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Readers, Aside from ongoing COVID infections and ...

SAN DIEGO - February 25, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of next-generation blood purification devices to treat cancer and life ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of next-generation blood purification technologies to treat ...

Why river cruise lines are excited that Celebrity is wading into the businessAlthough a new brand means more competition for companies already on the water, it also could introduce river cruising ...

Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. Dear Reader, Blood purification technologies have emerged to become ...

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Sigyn ...

In this regard, Sigyn TherapyTM is a candidate first-line countermeasure to address viral threats, yet it also offers a mechanism to potentially enhance and prolong the lives of the 550,00 ...